Atlas Trials

Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer

Clinical trial NCT06660147 · COMPLETED

Trial details

NCT number
NCT06660147
Sponsor
ARCAGY/ GINECO GROUP
Status
COMPLETED
Study type
OBSERVATIONAL
Ovarian Cancer
Start date
2023-12-11
Primary completion
2025-01-21
Enrollment
243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.